Search

everythinglearnresearchcommunity

for

Search:↓

60% of women who didn't respond to 5% minoxidil for hair loss showed significant improvement with a 15% minoxidil solution.

People with androgenetic alopecia often experience high stress, but the stress doesn't affect how the disease progresses or how well different treatments work.

Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.

The document concludes that early diagnosis and treatment are key for pediatric hair loss disorders, and addressing the emotional effects on children is important.

Both Betasalic ointment and 5% minoxidil are effective and safe for treating Alopecia Areata.

Hair loss in women, often not related to male hormones, increases with age and can cause significant emotional distress.

Minoxidil can regrow hair, but cyproterone acetate doesn't help when used together.

The treatment with an oral drug and topical lotion is effective and well-tolerated for hair loss after COVID-19.

Alopecia Areata is a hair loss condition affecting all genders, often linked to other diseases, with treatments available but varying success rates.

The document concludes that "hot comb alopecia" is now called "central cicatricial centrifugal alopecia" and its causes are complex.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

Monilethrix is a rare, inherited condition causing fragile hair and hair loss, with no cure but some treatments may help.

Combining topical delgocitinib with a 308-nm excimer laser can effectively treat severe alopecia areata and vitiligo.

Dermoscopy is a useful tool for diagnosing and managing topical steroid dependent face.

Recognizing scalp symptoms in PRP is crucial for proper diagnosis and treatment.

Minoxidil solution had low effect, causing 99% to stop using it.

Androgenetic alopecia, a genetic disorder affecting up to 50% of adults, is caused by an excessive response to androgens leading to hair follicle shrinkage. Treatments include FDA-approved drugs, other therapies like low-dose oral minoxidil, and hair transplantation.

Women's hair loss can be due to hormonal changes and various conditions, with treatments focusing on stopping progression and managing symptoms.

Alopecia areata is an unpredictable autoimmune hair loss condition, treated based on severity, with half of patients regrowing hair within a year without treatment.

Polymeric nanohydrogels show potential for skin drug delivery but have concerns like toxicity and regulatory hurdles.

Betamethasone dipropionate lotion is more effective than minoxidil solution for treating Alopecia Areata.

UV light might cause excessive hair growth by increasing PGE2 in the skin.

Androgenetic alopecia can be treated with minoxidil and finasteride, requiring long-term use and patient cooperation.

Dutasteride is the most studied alternative drug for androgenetic alopecia, but more high-quality research is needed.

The SULT1A1 enzyme booster improves minoxidil effectiveness in treating hair loss, especially in females.

Topical minoxidil 1% and 2% are twice as effective as placebo for female pattern hair loss.

Minoxidil mixed with 2-hydroxypropyl-β-cyclodextrin in water can improve hair growth more than minoxidil alone.

Most people with Alopecia Areata don't get treatment within a year; it's costly and often comes with other health issues.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Most dermatologists use and find oral minoxidil effective and tolerable for hair loss treatment.